CLINICAL_TRIALS
trial_result
· 2024-07-29
Clinical Trial Update: The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach [Phase 3]
Summary
The Phase 3 TAPIR trial evaluates prednisone in remission for granulomatosis with polyangiitis. The trial is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of South Florida | Conditions: Granulomatosis With Polyangiitis, Wegener Granulomatosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING